番茄社区app

The alleged unwarranted procedures on former patients date back to 2010

Dazukibart targets specific molecular pathology of chronic systemic autoimmune disease

VA study provides reassurance

Alternative to vaccination proves mettle in French study

Benefits from 3-month online intervention lasted 2 years, but trial lacked control group

Achieving remission and addressing CV risk factors made a big difference in Greek study

Hypothesized, but evidence not as clear until now

Leading adalimumab brand still dominates market, but net spending plummeted

Off-the-shelf drug reduces skin inflammation in animal models and human cell culture

Case-control study reinforces connection between inflammation and HFpEF

Fewer complications and flares occur for those who achieve the target, even intermittently

Genicular artery embolization could help put off the need for knee replacement surgery

Small trial suggests a simpler path to defeat systemic sclerosis

All drugs except one remained more expensive in the U.S.